Literature DB >> 18626895

Protein refolding at high concentration using size-exclusion chromatography.

B Batas1, J B Chaudhuri.   

Abstract

A new method to improve refolding yields and to increase the concentration of refolded proteins in a single operation has been developed. The method uses size-exclusion chromatography matrices to perform buffer exchange, aggregate removal, and the folding reaction. The reduced diffusion of proteins in gel-filtration media has been shown to suppress the nonspecific interactions of partially folded molecules, thus reducing aggregation. Hen egg white lysozyme (HEWL) and bovine carbonic anhydrase (CAB) were successfully refolded from initial protein concentrations of up to 80 mg/mL using Sephacryl S-100 (HR). The aggregation reaction for lysozyme was reduced and was only detected at the highest protein concentration used. The average recovery of lysozyme was 63%, with an average specific activity of 104%. Carbonic anhydrase experiments also showed that aggregation was suppressed and the average protein recovery from the column was 56%, with a specific activity of 81%. This process enables refolding and the purification of active species to be achieved in a single step.

Entities:  

Year:  1996        PMID: 18626895     DOI: 10.1002/(SICI)1097-0290(19960405)50:1<16::AID-BIT3>3.0.CO;2-4

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  10 in total

Review 1.  Production of active eukaryotic proteins through bacterial expression systems: a review of the existing biotechnology strategies.

Authors:  Sudhir Sahdev; Sunil K Khattar; Kulvinder Singh Saini
Journal:  Mol Cell Biochem       Date:  2007-09-12       Impact factor: 3.396

2.  Purified recombinant phage lysin LySMP: an extensive spectrum of lytic activity for swine streptococci.

Authors:  Y Wang; J H Sun; C P Lu
Journal:  Curr Microbiol       Date:  2009-03-07       Impact factor: 2.188

Review 3.  Protein recovery from inclusion bodies of Escherichia coli using mild solubilization process.

Authors:  Anupam Singh; Vaibhav Upadhyay; Arun Kumar Upadhyay; Surinder Mohan Singh; Amulya Kumar Panda
Journal:  Microb Cell Fact       Date:  2015-03-25       Impact factor: 5.328

Review 4.  Production strategies for active heme-containing peroxidases from E. coli inclusion bodies - a review.

Authors:  Britta Eggenreich; Melissa Willim; David Johannes Wurm; Christoph Herwig; Oliver Spadiut
Journal:  Biotechnol Rep (Amst)       Date:  2016-03-24

5.  Purification and interactions of the MucA' and MucB proteins constituting the DNA polymerase RI.

Authors:  Petr Grúz; Kei-Ichi Sugiyama; Masamitsu Honma; Takehiko Nohmi
Journal:  Genes Environ       Date:  2019-05-02

Review 6.  Protein folding liquid chromatography and its recent developments.

Authors:  Xindu Geng; Chaozhan Wang
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2006-11-20       Impact factor: 3.205

7.  Structural insights into protein folding, stability and activity using in vivo perdeuteration of hen egg-white lysozyme.

Authors:  Joao Ramos; Valerie Laux; Michael Haertlein; Elisabetta Boeri Erba; Katherine E McAuley; V Trevor Forsyth; Estelle Mossou; Sine Larsen; Annette E Langkilde
Journal:  IUCrJ       Date:  2021-03-06       Impact factor: 4.769

8.  The impact of folding modes and deuteration on the atomic resolution structure of hen egg-white lysozyme.

Authors:  Joao Ramos; Valerie Laux; Michael Haertlein; V Trevor Forsyth; Estelle Mossou; Sine Larsen; Annette E Langkilde
Journal:  Acta Crystallogr D Struct Biol       Date:  2021-11-17       Impact factor: 7.652

Review 9.  Downstream processing of recombinant human insulin and its analogues production from E. coli inclusion bodies.

Authors:  Yin Yin Siew; Wei Zhang
Journal:  Bioresour Bioprocess       Date:  2021-07-27

10.  Strategies for the recovery of active proteins through refolding of bacterial inclusion body proteins.

Authors:  Luis Felipe Vallejo; Ursula Rinas
Journal:  Microb Cell Fact       Date:  2004-09-02       Impact factor: 5.328

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.